This study is to evaluate the seroprevalence of neutralizing antibodies against Japanese encephalitis (JE) virus in children aged 6 years who were previously administered with 5 different immunization strategies by JE attenuated live vaccine (JEV-L) or/and inactivated vaccine (JEV-I). The secondary objective is to evaluate the immunogenicity of the booster dose of JEV-I at 6 years old for those previously immunized with 3 doses of JEV-I or those sequential administered with 1 dose of JEV-L and another dose of JEV-I.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Proportions of seropositivity of neutralizing antibodies against JE at the age of 6
Timeframe: At the age of 6. Test immediately after enrollment by a dose of blood sample.
Geometric Mean Titers (GMTs) or Median antibody titers for children aged 6 years
Timeframe: At the age of 6. Test immediately after enrollment by a dose of blood sample.